Showing results (431-440 of 617) with videos related to

Sort By:
Pageof 62
Cancer Immunology, Immunotherapy : CII|November 25, 2000
Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptidesB W Anderson, A P Kudelka, T Honda, et al.
American Journal of Obstetrics and Gynecology|January 17, 2025
Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumorsAllison L Brodsky, Alejandra Flores Legarreta, Jeffrey A How, et al.
Obstetrics and Gynecology|July 29, 2010
Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovaryKathleen M Schmeler, Xia Tao, Michael Frumovitz, et al.
Oncology Reports|January 14, 2004
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissuesAtac Baykal, Jennifer A Thompson, Xiao-Chun Xu, et al.
Cancer|September 15, 1987
Prognostic factors in stage II endometrial carcinomaD M Larson, L J Copeland, H S Gallager, et al.
Obstetrics and Gynecology|March 2, 2005
Risk factors for young premenopausal women with endometrial cancerPamela T Soliman, Jonathan C Oh, Kathleen M Schmeler, et al.
Methods (San Diego, Calif.)|July 28, 2006
High-throughput zebrafish histologyNicole A Sabaliauskas, Christina A Foutz, Jason R Mest, et al.
Gynecologic Oncology|October 1, 1992
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsideredD M Gershenson, M F Mitchell, N Atkinson, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 1, 2011
Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesisMelinda S Yates, Larissa A Meyer, Michael T Deavers, et al.
Pageof 62